Literature DB >> 19057458

Nontypeable Haemophilus influenzae as a pathogen in children.

Timothy F Murphy1, Howard Faden, Lauren O Bakaletz, Jennelle M Kyd, Arne Forsgren, Jose Campos, Mumtaz Virji, Stephen I Pelton.   

Abstract

Nontypeable Haemophilus influenzae is a significant pathogen in children, causing otitis media, sinusitis, conjunctivitis, pneumonia, and occasionally invasive infections. H. influenzae type b conjugate vaccines have no effect on infections caused by nontypeable strains because nontypeable strains are nonencapsulated. Approximately, one-third of episodes of otitis media are caused by nontypeable H. influenzae and the bacterium is the most common cause of recurrent otitis media. Recent progress in elucidating molecular mechanisms of pathogenesis, understanding the role of biofilms in otitis media and an increasing understanding of immune responses have potential for development of novel strategies to improve prevention and treatment of otitis media caused by nontypeable H. influenzae. Feasibility of vaccination for prevention of otitis media due to nontypeable H. influenzae was recently demonstrated in a clinical trial with a vaccine that included the surface virulence factor, protein D.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19057458     DOI: 10.1097/INF.0b013e318184dba2

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  95 in total

1.  Overlapping and complementary oxidative stress defense mechanisms in nontypeable Haemophilus influenzae.

Authors:  Alistair Harrison; Beth D Baker; Robert S Munson
Journal:  J Bacteriol       Date:  2014-11-03       Impact factor: 3.490

2.  Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Haemophilus influenzae Increases Complement-Mediated Killing.

Authors:  Jeroen D Langereis; Eva S van der Pasch; Marien I de Jonge
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro.

Authors:  Carmen Puig; Sara Marti; Peter W M Hermans; Marien I de Jonge; Carmen Ardanuy; Josefina Liñares; Jeroen D Langereis
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

4.  Use of the EpiAirway model for characterizing long-term host-pathogen interactions.

Authors:  Dabin Ren; Dayle A Daines
Journal:  J Vis Exp       Date:  2011-09-02       Impact factor: 1.355

5.  Ferric uptake regulator and its role in the pathogenesis of nontypeable Haemophilus influenzae.

Authors:  Alistair Harrison; Estevan A Santana; Blake R Szelestey; David E Newsom; Peter White; Kevin M Mason
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

6.  Urease operon and urease activity in commensal and disease-causing nontypeable Haemophilus influenzae.

Authors:  Lixin Zhang; Mayuri Patel; Jingping Xie; Gregg S Davis; Carl F Marrs; Janet R Gilsdorf
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

7.  Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity.

Authors:  Teresia Hallström; Fredrik Resman; Mikael Ristovski; Kristian Riesbeck
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

8.  Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus.

Authors:  Kirk W McCrea; Jingping Xie; Carl F Marrs; Janet R Gilsdorf
Journal:  BMC Microbiol       Date:  2010-11-12       Impact factor: 3.605

9.  The dppBCDF gene cluster of Haemophilus influenzae: Role in heme utilization.

Authors:  Daniel J Morton; Thomas W Seale; Timothy M Vanwagoner; Paul W Whitby; Terrence L Stull
Journal:  BMC Res Notes       Date:  2009-08-24

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.